USPTO serial 98207152
EVIDA
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- HELLMAN, ELI J
- Law office
- TMO LAW OFFICE 131
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with EVIDA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelley B. Harrington
Kelley B. Harrington Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700ATTN: IP Docketing DepartmentWashington, DC 20004-2400Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics | ACTIVE | — |
| 044 | Medical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 23, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 22, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 22, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 17, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 17, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 16, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 15, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 14, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 31, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 19, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 19, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 19, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 19, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 19, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 19, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 19, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 5, 2023 | NWAP | NEW APPLICATION ENTERED | — |